Regeneron’s Share Price Soars as New Deal with sanofi-aventis is Signed

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)

Published: 8 Jan-2008

DOI: 10.3833/pdr.v2008.i91.232     ISSN: 1756-7874

Section: Research & Development



Regeneron Pharmaceuticals and Sanofi-Aventis entered into research collaboration to discover, develop and commercialize human therapeutic antibodies utilizing Regeneron’s proprietary VelociSuite technologies including VelocImmune®...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details